| This article needs to be updated. The reason given is: no files for 2006 are listed at the cited source, but files for 2013 are there; NLM releases this information annually. Please help update this article to reflect recent events or newly available information. (February 2020) |
The following is a partial list of the "C" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).
This list continues the information at List of MeSH codes (C03). Codes following these are found at List of MeSH codes (C05). For other MeSH codes, see List of MeSH codes.
The source for this content is the set of 2006 MeSH Trees from the NLM.
- MeSH C04.557.337.100 – enzootic bovine leukosis
- MeSH C04.557.337.372 – leukemia, experimental
- MeSH C04.557.337.372.216 – avian leukosis
- MeSH C04.557.337.372.594 – leukemia L1210
- MeSH C04.557.337.372.602 – leukemia L5178
- MeSH C04.557.337.372.782 – leukemia p388
- MeSH C04.557.337.385 – leukemia, feline
- MeSH C04.557.337.415 – leukemia, hairy cell
- MeSH C04.557.337.415.700 – leukemia, t-cell, htlv-ii-associated
- MeSH C04.557.337.428 – leukemia, lymphocytic
- MeSH C04.557.337.428.500 – leukemia, b-cell
- MeSH C04.557.337.428.500.100 – leukemia, b-cell, acute
- MeSH C04.557.337.428.500.125 – leukemia, B-Cell, chronic
- MeSH C04.557.337.428.500.500 – leukemia, pre-b-cell
- MeSH C04.557.337.428.511 – leukemia, lymphocytic, acute
- MeSH C04.557.337.428.511.100 – leukemia, b-cell, acute
- MeSH C04.557.337.428.511.225 – leukemia, calla-positive
- MeSH C04.557.337.428.511.400 – leukemia, lymphocytic, acute, L1
- MeSH C04.557.337.428.511.410 – leukemia, lymphocytic, acute, L2
- MeSH C04.557.337.428.511.500 – leukemia, mixed-cell
- MeSH C04.557.337.428.511.550 – leukemia, null-cell
- MeSH C04.557.337.428.511.800 – leukemia, t-cell, acute
- MeSH C04.557.337.428.511.800.300 – leukemia-lymphoma, t-cell, acute, htlv-i-associated
- MeSH C04.557.337.428.550 – leukemia, lymphocytic, chronic
- MeSH C04.557.337.428.550.250 – leukemia, B-Cell, chronic
- MeSH C04.557.337.428.550.675 – leukemia, prolymphocytic
- MeSH C04.557.337.428.550.800 – leukemia, T-Cell, chronic
- MeSH C04.557.337.428.580 – leukemia, t-cell
- MeSH C04.557.337.428.580.100 – leukemia, t-cell, acute
- MeSH C04.557.337.428.580.100.300 – leukemia-lymphoma, t-cell, acute, htlv-i-associated
- MeSH C04.557.337.428.580.125 – leukemia, T-Cell, chronic
- MeSH C04.557.337.428.580.400 – leukemia, t-cell, htlv-ii-associated
- MeSH C04.557.337.440 – leukemia, mast-cell
- MeSH C04.557.337.539 – leukemia, myeloid
- MeSH C04.557.337.539.250 – leukemia, myeloid, chronic
- MeSH C04.557.337.539.250.200 – blast crisis
- MeSH C04.557.337.539.250.275 – leukemia, monocytic, chronic
- MeSH C04.557.337.539.250.300 – leukemia, myeloid, aggressive-phase
- MeSH C04.557.337.539.250.400 – leukemia, myeloid, chronic-phase
- MeSH C04.557.337.539.250.500 – leukemia, myelomonocytic, chronic
- MeSH C04.557.337.539.250.550 – leukemia, neutrophilic, chronic
- MeSH C04.557.337.539.500 – leukemia, myeloid, philadelphia-negative
- MeSH C04.557.337.539.510 – leukemia, myeloid, philadelphia-positive
- MeSH C04.557.337.539.520 – leukemia, myelomonocytic, acute
- MeSH C04.557.337.539.550 – leukemia, nonlymphocytic, acute
- MeSH C04.557.337.539.550.125 – leukemia, basophilic, acute
- MeSH C04.557.337.539.550.300 – leukemia, eosinophilic, acute
- MeSH C04.557.337.539.550.325 – leukemia, erythroblastic, acute
- MeSH C04.557.337.539.550.440 – leukemia, mast-cell
- MeSH C04.557.337.539.550.450 – leukemia, megakaryocytic, acute
- MeSH C04.557.337.539.550.484 – leukemia, monocytic, acute
- MeSH C04.557.337.539.550.512 – leukemia, myelocytic, acute
- MeSH C04.557.337.539.550.700 – leukemia, promyelocytic, acute
- MeSH C04.557.337.539.775 – sarcoma, granulocytic
- MeSH C04.557.337.595 – leukemia, plasmacytic
- MeSH C04.557.337.650 – leukemia, radiation-induced
- MeSH C04.557.337.706 – leukemia, subleukemic
- MeSH C04.557.386.345 – histiocytosis, malignant
- MeSH C04.557.386.355 – hodgkin disease
- MeSH C04.557.386.390 – immunoproliferative small intestinal disease
- MeSH C04.557.386.480 – lymphoma, non-hodgkin
- MeSH C04.557.386.480.150 – B-cell lymphoma
- MeSH C04.557.386.480.150.165 – burkitt lymphoma
- MeSH C04.557.386.480.150.450 – lymphoma, aids-related
- MeSH C04.557.386.480.150.570 – lymphoma, mucosa-associated lymphoid tissue
- MeSH C04.557.386.480.150.700 – lymphoma, small-cell
- MeSH C04.557.386.480.300 – lymphoma, diffuse
- MeSH C04.557.386.480.300.300 – lymphoma, large-cell, diffuse
- MeSH C04.557.386.480.300.450 – lymphoma, large-cell, immunoblastic
- MeSH C04.557.386.480.300.475 – lymphoma, lymphoblastic
- MeSH C04.557.386.480.300.500 – lymphoma, mixed-cell, diffuse
- MeSH C04.557.386.480.300.725 – lymphoma, small cleaved-cell, diffuse
- MeSH C04.557.386.480.300.725.500 – lymphoma, mantle-cell
- MeSH C04.557.386.480.300.750 – lymphoma, small lymphocytic
- MeSH C04.557.386.480.300.775 – lymphoma, small noncleaved-cell
- MeSH C04.557.386.480.350 – lymphoma, follicular
- MeSH C04.557.386.480.350.350 – lymphoma, large-cell, follicular
- MeSH C04.557.386.480.350.525 – lymphoma, mixed-cell, follicular
- MeSH C04.557.386.480.350.750 – lymphoma, small cleaved-cell, follicular
- MeSH C04.557.386.480.425 – lymphoma, high-grade
- MeSH C04.557.386.480.425.450 – lymphoma, large-cell, immunoblastic
- MeSH C04.557.386.480.425.475 – lymphoma, lymphoblastic
- MeSH C04.557.386.480.425.775 – lymphoma, small noncleaved-cell
- MeSH C04.557.386.480.425.775.165 – burkitt lymphoma
- MeSH C04.557.386.480.450 – lymphoma, intermediate-grade
- MeSH C04.557.386.480.450.300 – lymphoma, large-cell, diffuse
- MeSH C04.557.386.480.450.350 – lymphoma, large-cell, follicular
- MeSH C04.557.386.480.450.500 – lymphoma, mixed-cell, diffuse
- MeSH C04.557.386.480.450.725 – lymphoma, small cleaved-cell, diffuse
- MeSH C04.557.386.480.450.725.500 – lymphoma, mantle-cell
- MeSH C04.557.386.480.475 – lymphoma, large-cell
- MeSH C04.557.386.480.475.300 – lymphoma, large-cell, diffuse
- MeSH C04.557.386.480.475.350 – lymphoma, large-cell, follicular
- MeSH C04.557.386.480.475.450 – lymphoma, large-cell, immunoblastic
- MeSH C04.557.386.480.475.465 – lymphoma, large-cell, ki-1
- MeSH C04.557.386.480.475.475 – lymphoma, lymphoblastic
- MeSH C04.557.386.480.500 – lymphoma, low-grade
- MeSH C04.557.386.480.500.525 – lymphoma, mixed-cell, follicular
- MeSH C04.557.386.480.500.570 – lymphoma, mucosa-associated lymphoid tissue
- MeSH C04.557.386.480.500.750 – lymphoma, small cleaved-cell, follicular
- MeSH C04.557.386.480.500.770 – lymphoma, small lymphocytic
- MeSH C04.557.386.480.550 – lymphoma, mixed-cell
- MeSH C04.557.386.480.550.500 – lymphoma, mixed-cell, diffuse
- MeSH C04.557.386.480.550.525 – lymphoma, mixed-cell, follicular
- MeSH C04.557.386.480.700 – lymphoma, small-cell
- MeSH C04.557.386.480.700.725 – lymphoma, small cleaved-cell, diffuse
- MeSH C04.557.386.480.700.725.500 – lymphoma, mantle-cell
- MeSH C04.557.386.480.700.730 – lymphoma, small cleaved-cell, follicular
- MeSH C04.557.386.480.700.750 – lymphoma, small lymphocytic
- MeSH C04.557.386.480.700.775 – lymphoma, small noncleaved-cell
- MeSH C04.557.386.480.750 – lymphoma, t-cell
- MeSH C04.557.386.480.750.475 – lymphoma, lymphoblastic
- MeSH C04.557.386.480.750.800 – lymphoma, t-cell, cutaneous
- MeSH C04.557.386.480.750.800.465 – lymphoma, large-cell, ki-1
- MeSH C04.557.386.480.750.800.550 – mycosis fungoides
- MeSH C04.557.386.480.750.800.775 – sezary syndrome
- MeSH C04.557.386.480.750.825 – lymphoma, t-cell, peripheral
- MeSH C04.557.386.480.875 – lymphoma, undifferentiated
- MeSH C04.557.386.480.875.300 – lymphoma, large-cell, diffuse
- MeSH C04.557.386.480.875.775 – lymphoma, small noncleaved-cell
- MeSH C04.557.386.480.875.775.165 – burkitt lymphoma
- MeSH C04.557.386.720 – plasmacytoma
- MeSH C04.557.386.720.550 – multiple myeloma
- MeSH C04.557.386.802 – reticuloendotheliosis
- MeSH C04.557.386.802.750 – mast-cell sarcoma
- MeSH C04.557.450.550 – neoplasms, adipose tissue
- MeSH C04.557.450.550.100 – angiolipoma
- MeSH C04.557.450.550.125 – angiomyolipoma
- MeSH C04.557.450.550.400 – lipoma
- MeSH C04.557.450.550.420 – liposarcoma
- MeSH C04.557.450.550.420.425 – liposarcoma, myxoid
- MeSH C04.557.450.550.710 – myelolipoma
- MeSH C04.557.450.565 – neoplasms, connective tissue
- MeSH C04.557.450.565.250 – chondroblastoma
- MeSH C04.557.450.565.265 – chondroma
- MeSH C04.557.450.565.265.270 – chondromatosis
- MeSH C04.557.450.565.280 – chondrosarcoma
- MeSH C04.557.450.565.280.280 – chondrosarcoma, mesenchymal
- MeSH C04.557.450.565.380 – giant cell tumors
- MeSH C04.557.450.565.380.380 – giant cell tumor of bone
- MeSH C04.557.450.565.465 – mastocytosis
- MeSH C04.557.450.565.465.249 – mastocytoma
- MeSH C04.557.450.565.465.500 – mastocytosis, cutaneous
- MeSH C04.557.450.565.465.500.500 – urticaria pigmentosa
- MeSH C04.557.450.565.465.750 – mastocytosis, systemic
- MeSH C04.557.450.565.465.750.500 – leukemia, mast-cell
- MeSH C04.557.450.565.465.875 – mast-cell sarcoma
- MeSH C04.557.450.565.540 – myofibroma
- MeSH C04.557.450.565.550 – myxoma
- MeSH C04.557.450.565.550.625 – neurothekeoma
- MeSH C04.557.450.565.560 – myxosarcoma
- MeSH C04.557.450.565.575 – neoplasms, bone tissue
- MeSH C04.557.450.565.575.400 – fibroma, ossifying
- MeSH C04.557.450.565.575.420 – giant cell tumor of bone
- MeSH C04.557.450.565.575.600 – osteoblastoma
- MeSH C04.557.450.565.575.610 – osteochondroma
- MeSH C04.557.450.565.575.610.615 – osteochondromatosis
- MeSH C04.557.450.565.575.610.615.325 – exostoses, multiple hereditary
- MeSH C04.557.450.565.575.625 – osteoma
- MeSH C04.557.450.565.575.625.625 – osteoma, osteoid
- MeSH C04.557.450.565.575.650 – osteosarcoma
- MeSH C04.557.450.565.575.650.655 – osteosarcoma, juxtacortical
- MeSH C04.557.450.565.575.650.800 – sarcoma, Ewing's
- MeSH C04.557.450.565.590 – neoplasms, fibrous tissue
- MeSH C04.557.450.565.590.340 – fibroma
- MeSH C04.557.450.565.590.340.345 – fibroma, desmoplastic
- MeSH C04.557.450.565.590.340.360 – fibroma, ossifying
- MeSH C04.557.450.565.590.340.400 – fibromatosis, abdominal
- MeSH C04.557.450.565.590.340.410 – fibromatosis, aggressive
- MeSH C04.557.450.565.590.350 – fibrosarcoma
- MeSH C04.557.450.565.590.350.320 – dermatofibrosarcoma
- MeSH C04.557.450.565.590.350.590 – neurofibrosarcoma
- MeSH C04.557.450.565.590.425 – histiocytoma
- MeSH C04.557.450.565.590.425.350 – histiocytoma, benign fibrous
- MeSH C04.557.450.565.590.425.360 – histiocytoma, malignant fibrous
- MeSH C04.557.450.565.590.550 – myofibromatosis
- MeSH C04.557.450.565.590.595 – neoplasms, fibroepithelial
- MeSH C04.557.450.565.590.595.050 – adenofibroma
- MeSH C04.557.450.565.590.595.150 – brenner tumor
- MeSH C04.557.450.565.590.595.350 – fibroadenoma
- MeSH C04.557.450.565.800 – sarcoma, clear cell
- MeSH C04.557.450.565.825 – sarcoma, small cell
- MeSH C04.557.450.565.835 – sarcoma, synovial
- MeSH C04.557.450.590 – neoplasms, muscle tissue
- MeSH C04.557.450.590.350 – granular cell tumor
- MeSH C04.557.450.590.450 – leiomyoma
- MeSH C04.557.450.590.450.125 – angiomyoma
- MeSH C04.557.450.590.450.455 – leiomyoma, epithelioid
- MeSH C04.557.450.590.450.465 – leiomyomatosis
- MeSH C04.557.450.590.455 – leiomyosarcoma
- MeSH C04.557.450.590.540 – myoma
- MeSH C04.557.450.590.540.700 – rhabdomyoma
- MeSH C04.557.450.590.550 – myosarcoma
- MeSH C04.557.450.590.550.660 – rhabdomyosarcoma
- MeSH C04.557.450.590.550.660.665 – rhabdomyosarcoma, alveolar
- MeSH C04.557.450.590.550.660.675 – rhabdomyosarcoma, embryonal
- MeSH C04.557.450.590.775 – sarcoma, alveolar soft part
- MeSH C04.557.450.590.800 – smooth muscle tumor
- MeSH C04.557.450.795 – sarcoma
- MeSH C04.557.450.795.135 – adenosarcoma
- MeSH C04.557.450.795.290 – carcinosarcoma
- MeSH C04.557.450.795.290.210 – carcinoma 256, walker
- MeSH C04.557.450.795.300 – chondrosarcoma
- MeSH C04.557.450.795.300.280 – chondrosarcoma, mesenchymal
- MeSH C04.557.450.795.350 – fibrosarcoma
- MeSH C04.557.450.795.350.320 – dermatofibrosarcoma
- MeSH C04.557.450.795.350.590 – neurofibrosarcoma
- MeSH C04.557.450.795.390 – hemangiosarcoma
- MeSH C04.557.450.795.400 – histiocytoma, malignant fibrous
- MeSH C04.557.450.795.455 – leiomyosarcoma
- MeSH C04.557.450.795.465 – liposarcoma
- MeSH C04.557.450.795.465.425 – liposarcoma, myxoid
- MeSH C04.557.450.795.480 – lymphangiosarcoma
- MeSH C04.557.450.795.530 – mixed tumor, mesodermal
- MeSH C04.557.450.795.550 – myosarcoma
- MeSH C04.557.450.795.550.660 – rhabdomyosarcoma
- MeSH C04.557.450.795.550.660.665 – rhabdomyosarcoma, alveolar
- MeSH C04.557.450.795.550.660.675 – rhabdomyosarcoma, embryonal
- MeSH C04.557.450.795.560 – myxosarcoma
- MeSH C04.557.450.795.620 – osteosarcoma
- MeSH C04.557.450.795.620.655 – osteosarcoma, juxtacortical
- MeSH C04.557.450.795.620.800 – sarcoma, Ewing's
- MeSH C04.557.450.795.650 – phyllodes tumor
- MeSH C04.557.450.795.775 – sarcoma, alveolar soft part
- MeSH C04.557.450.795.800 – sarcoma, clear cell
- MeSH C04.557.450.795.820 – sarcoma, endometrial stromal
- MeSH C04.557.450.795.830 – sarcoma, experimental
- MeSH C04.557.450.795.830.760 – sarcoma 37
- MeSH C04.557.450.795.830.780 – sarcoma 180
- MeSH C04.557.450.795.830.800 – sarcoma, avian
- MeSH C04.557.450.795.830.850 – sarcoma, yoshida
- MeSH C04.557.450.795.840 – sarcoma, granulocytic
- MeSH C04.557.450.795.850 – sarcoma, kaposi
- MeSH C04.557.450.795.870 – sarcoma, small cell
- MeSH C04.557.450.795.875 – sarcoma, synovial
- MeSH C04.557.465.200 – carcinoma, embryonal
- MeSH C04.557.465.220 – chordoma
- MeSH C04.557.465.280 – dermoid cyst
- MeSH C04.557.465.330 – germinoma
- MeSH C04.557.465.330.300 – dysgerminoma
- MeSH C04.557.465.330.800 – seminoma
- MeSH C04.557.465.420 – gonadoblastoma
- MeSH C04.557.465.510 – mesonephroma
- MeSH C04.557.465.510.350 – endodermal sinus tumor
- MeSH C04.557.465.625 – neuroectodermal tumors
- MeSH C04.557.465.625.200 – craniopharyngioma
- MeSH C04.557.465.625.600 – neoplasms, neuroepithelial
- MeSH C04.557.465.625.600.355 – ganglioneuroma
- MeSH C04.557.465.625.600.380 – glioma
- MeSH C04.557.465.625.600.380.080 – astrocytoma
- MeSH C04.557.465.625.600.380.080.335 – glioblastoma
- MeSH C04.557.465.625.600.380.080.667 – optic nerve glioma
- MeSH C04.557.465.625.600.380.290 – ependymoma
- MeSH C04.557.465.625.600.380.290.390 – glioma, subependymal
- MeSH C04.557.465.625.600.380.350 – ganglioglioma
- MeSH C04.557.465.625.600.380.400 – gliosarcoma
- MeSH C04.557.465.625.600.380.515 – medulloblastoma
- MeSH C04.557.465.625.600.380.590 – oligodendroglioma
- MeSH C04.557.465.625.600.380.795 – optic nerve glioma
- MeSH C04.557.465.625.600.580 – neurocytoma
- MeSH C04.557.465.625.600.590 – neuroectodermal tumors, primitive
- MeSH C04.557.465.625.600.590.500 – medulloblastoma
- MeSH C04.557.465.625.600.590.650 – neuroectodermal tumors, primitive, peripheral
- MeSH C04.557.465.625.600.590.650.550 – neuroblastoma
- MeSH C04.557.465.625.600.590.650.550.150 – esthesioneuroblastoma, olfactory
- MeSH C04.557.465.625.600.590.650.550.300 – ganglioneuroblastoma
- MeSH C04.557.465.625.600.657 – pinealoma
- MeSH C04.557.465.625.600.725 – retinoblastoma
- MeSH C04.557.465.625.630 – neuroectodermal tumor, melanotic
- MeSH C04.557.465.625.650 – neuroendocrine tumors
- MeSH C04.557.465.625.650.025 – adenoma, acidophil
- MeSH C04.557.465.625.650.075 – adenoma, basophil
- MeSH C04.557.465.625.650.095 – adenoma, chromophobe
- MeSH C04.557.465.625.650.135 – apudoma
- MeSH C04.557.465.625.650.200 – carcinoid tumor
- MeSH C04.557.465.625.650.200.500 – malignant carcinoid syndrome
- MeSH C04.557.465.625.650.200.500.205 – carcinoid heart disease
- MeSH C04.557.465.625.650.240 – carcinoma, neuroendocrine
- MeSH C04.557.465.625.650.240.315 – carcinoma, medullary
- MeSH C04.557.465.625.650.240.325 – carcinoma, merkel cell
- MeSH C04.557.465.625.650.240.390 – carcinoma, small cell
- MeSH C04.557.465.625.650.240.695 – somatostatinoma
- MeSH C04.557.465.625.650.240.847 – vipoma
- MeSH C04.557.465.625.650.510 – melanoma
- MeSH C04.557.465.625.650.510.385 – hutchinson's melanotic freckle
- MeSH C04.557.465.625.650.510.515 – melanoma, amelanotic
- MeSH C04.557.465.625.650.510.525 – melanoma, experimental
- MeSH C04.557.465.625.650.595 – neurilemmoma
- MeSH C04.557.465.625.650.595.610 – neuroma, acoustic
- MeSH C04.557.465.625.650.595.610.500 – neurofibromatosis 2
- MeSH C04.557.465.625.650.700 – paraganglioma
- MeSH C04.557.465.625.650.700.705 – paraganglioma, extra-adrenal
- MeSH C04.557.465.625.650.700.705.220 – carotid body tumor
- MeSH C04.557.465.625.650.700.705.340 – glomus jugulare tumor
- MeSH C04.557.465.625.650.700.705.360 – glomus tympanicum tumor
- MeSH C04.557.465.625.650.700.725 – pheochromocytoma
- MeSH C04.557.465.900 – teratocarcinoma
- MeSH C04.557.465.910 – teratoma
- MeSH C04.557.465.910.850 – struma ovarii
- MeSH C04.557.465.955 – trophoblastic neoplasms
- MeSH C04.557.465.955.207 – choriocarcinoma
- MeSH C04.557.465.955.207.750 – choriocarcinoma, non-gestational
- MeSH C04.557.465.955.207.875 – trophoblastic tumor, placental site
- MeSH C04.557.465.955.416 – gestational trophoblastic neoplasms
- MeSH C04.557.465.955.416.202 – choriocarcinoma
- MeSH C04.557.465.955.416.202.875 – trophoblastic tumor, placental site
- MeSH C04.557.465.955.416.812 – hydatidiform mole
- MeSH C04.557.465.955.416.812.500 – hydatidiform mole, invasive
- MeSH C04.557.470.035 – adenoma
- MeSH C04.557.470.035.012 – acth-secreting pituitary adenoma
- MeSH C04.557.470.035.025 – adenoma, acidophil
- MeSH C04.557.470.035.075 – adenoma, basophil
- MeSH C04.557.470.035.085 – adenoma, bile duct
- MeSH C04.557.470.035.095 – adenoma, chromophobe
- MeSH C04.557.470.035.100 – adenoma, islet cell
- MeSH C04.557.470.035.100.852 – insulinoma
- MeSH C04.557.470.035.120 – adenoma, liver cell
- MeSH C04.557.470.035.140 – adenoma, oxyphilic
- MeSH C04.557.470.035.155 – adenoma, pleomorphic
- MeSH C04.557.470.035.175 – adenoma, sweat gland
- MeSH C04.557.470.035.175.125 – acrospiroma, eccrine
- MeSH C04.557.470.035.175.375 – hidrocystoma
- MeSH C04.557.470.035.175.800 – syringoma
- MeSH C04.557.470.035.185 – adenoma, villous
- MeSH C04.557.470.035.200 – adenomatoid tumor
- MeSH C04.557.470.035.210 – adenomatosis, pulmonary
- MeSH C04.557.470.035.215 – adenomatous polyps
- MeSH C04.557.470.035.215.100 – adenomatous polyposis coli
- MeSH C04.557.470.035.215.100.500 – gardner syndrome
- MeSH C04.557.470.035.232 – adrenal rest tumor
- MeSH C04.557.470.035.250 – apudoma
- MeSH C04.557.470.035.320 – cystadenoma
- MeSH C04.557.470.035.320.225 – cystadenoma, mucinous
- MeSH C04.557.470.035.320.230 – cystadenoma, papillary
- MeSH C04.557.470.035.320.240 – cystadenoma, serous
- MeSH C04.557.470.035.415 – growth hormone-secreting pituitary adenoma
- MeSH C04.557.470.035.510 – mesothelioma
- MeSH C04.557.470.035.510.515 – mesothelioma, cystic
- MeSH C04.557.470.035.625 – prolactinoma
- MeSH C04.557.470.200 – carcinoma
- MeSH C04.557.470.200.025 – adenocarcinoma
- MeSH C04.557.470.200.025.030 – adenocarcinoma, bronchiolo-alveolar
- MeSH C04.557.470.200.025.045 – adenocarcinoma, clear cell
- MeSH C04.557.470.200.025.060 – adenocarcinoma, follicular
- MeSH C04.557.470.200.025.060.225 – carcinoma, papillary, follicular
- MeSH C04.557.470.200.025.075 – adenocarcinoma, mucinous
- MeSH C04.557.470.200.025.085 – adenocarcinoma, papillary
- MeSH C04.557.470.200.025.085.225 – carcinoma, papillary, follicular
- MeSH C04.557.470.200.025.095 – adenocarcinoma, scirrhous
- MeSH C04.557.470.200.025.095.410 – linitis plastica
- MeSH C04.557.470.200.025.105 – adenocarcinoma, sebaceous
- MeSH C04.557.470.200.025.152 – adrenocortical carcinoma
- MeSH C04.557.470.200.025.200 – carcinoid tumor
- MeSH C04.557.470.200.025.200.500 – malignant carcinoid syndrome
- MeSH C04.557.470.200.025.200.500.205 – carcinoid heart disease
- MeSH C04.557.470.200.025.215 – carcinoma, acinar cell
- MeSH C04.557.470.200.025.220 – carcinoma, adenoid cystic
- MeSH C04.557.470.200.025.232 – carcinoma, ductal
- MeSH C04.557.470.200.025.232.500 – carcinoma, ductal, breast
- MeSH C04.557.470.200.025.232.750 – carcinoma, pancreatic ductal
- MeSH C04.557.470.200.025.240 – carcinoma, endometrioid
- MeSH C04.557.470.200.025.255 – carcinoma, hepatocellular
- MeSH C04.557.470.200.025.275 – carcinoma, intraductal, noninfiltrating
- MeSH C04.557.470.200.025.275.625 – paget's disease, mammary
- MeSH C04.557.470.200.025.290 – carcinoma, islet cell
- MeSH C04.557.470.200.025.290.500 – gastrinoma
- MeSH C04.557.470.200.025.290.750 – glucagonoma
- MeSH C04.557.470.200.025.305 – carcinoma, lobular
- MeSH C04.557.470.200.025.340 – carcinoma, mucoepidermoid
- MeSH C04.557.470.200.025.370 – carcinoma, neuroendocrine
- MeSH C04.557.470.200.025.370.315 – carcinoma, medullary
- MeSH C04.557.470.200.025.370.325 – carcinoma, merkel cell
- MeSH C04.557.470.200.025.370.390 – carcinoma, small cell
- MeSH C04.557.470.200.025.370.695 – somatostatinoma
- MeSH C04.557.470.200.025.370.847 – vipoma
- MeSH C04.557.470.200.025.390 – carcinoma, renal cell
- MeSH C04.557.470.200.025.415 – carcinoma, signet ring cell
- MeSH C04.557.470.200.025.415.410 – krukenberg tumor
- MeSH C04.557.470.200.025.420 – carcinoma, skin appendage
- MeSH C04.557.470.200.025.450 – cholangiocarcinoma
- MeSH C04.557.470.200.025.455 – choriocarcinoma
- MeSH C04.557.470.200.025.455.750 – choriocarcinoma, non-gestational
- MeSH C04.557.470.200.025.455.875 – trophoblastic tumor, placental site
- MeSH C04.557.470.200.025.480 – cystadenocarcinoma
- MeSH C04.557.470.200.025.480.225 – cystadenocarcinoma, mucinous
- MeSH C04.557.470.200.025.480.230 – cystadenocarcinoma, papillary
- MeSH C04.557.470.200.025.480.240 – cystadenocarcinoma, serous
- MeSH C04.557.470.200.025.540 – klatskin's tumor
- MeSH C04.557.470.200.025.660 – paget's disease, extramammary
- MeSH C04.557.470.200.025.715 – pulmonary adenomatosis, ovine
- MeSH C04.557.470.200.150 – carcinoma, adenosquamous
- MeSH C04.557.470.200.165 – carcinoma, basal cell
- MeSH C04.557.470.200.165.150 – basal cell nevus syndrome
- MeSH C04.557.470.200.170 – carcinoma, basosquamous
- MeSH C04.557.470.200.200 – carcinoma, ehrlich tumor
- MeSH C04.557.470.200.220 – carcinoma, giant cell
- MeSH C04.557.470.200.240 – carcinoma in situ
- MeSH C04.557.470.200.240.250 – cervical intraepithelial neoplasia
- MeSH C04.557.470.200.240.500 – prostatic intraepithelial neoplasia
- MeSH C04.557.470.200.255 – carcinoma, krebs 2
- MeSH C04.557.470.200.260 – carcinoma, large cell
- MeSH C04.557.470.200.280 – carcinoma, lewis lung
- MeSH C04.557.470.200.300 – carcinoma, non-small-cell lung
- MeSH C04.557.470.200.360 – carcinoma, papillary
- MeSH C04.557.470.200.400 – carcinoma, squamous cell
- MeSH C04.557.470.200.400.130 – bowen's disease
- MeSH C04.557.470.200.430 – carcinoma, transitional cell
- MeSH C04.557.470.200.450 – carcinoma, verrucous
- MeSH C04.557.470.550 – neoplasms, adnexal and skin appendage
- MeSH C04.557.470.550.105 – adenocarcinoma, sebaceous
- MeSH C04.557.470.550.175 – adenoma, sweat gland
- MeSH C04.557.470.550.175.125 – acrospiroma, eccrine
- MeSH C04.557.470.550.175.375 – hidrocystoma
- MeSH C04.557.470.550.175.800 – syringoma
- MeSH C04.557.470.550.420 – carcinoma, skin appendage
- MeSH C04.557.470.565 – neoplasms, basal cell
- MeSH C04.557.470.565.165 – carcinoma, basal cell
- MeSH C04.557.470.565.165.150 – basal cell nevus syndrome
- MeSH C04.557.470.565.170 – carcinoma, basosquamous
- MeSH C04.557.470.565.625 – pilomatrixoma
- MeSH C04.557.470.590 – neoplasms, cystic, mucinous, and serous
- MeSH C04.557.470.590.075 – adenocarcinoma, mucinous
- MeSH C04.557.470.590.340 – carcinoma, mucoepidermoid
- MeSH C04.557.470.590.415 – carcinoma, signet ring cell
- MeSH C04.557.470.590.415.410 – krukenberg tumor
- MeSH C04.557.470.590.480 – cystadenocarcinoma
- MeSH C04.557.470.590.480.225 – cystadenocarcinoma, mucinous
- MeSH C04.557.470.590.480.230 – cystadenocarcinoma, papillary
- MeSH C04.557.470.590.480.240 – cystadenocarcinoma, serous
- MeSH C04.557.470.590.485 – cystadenoma
- MeSH C04.557.470.590.485.225 – cystadenoma, mucinous
- MeSH C04.557.470.590.485.230 – cystadenoma, papillary
- MeSH C04.557.470.590.485.240 – cystadenoma, serous
- MeSH C04.557.470.590.580 – mucoepidermoid tumor
- MeSH C04.557.470.590.782 – pseudomyxoma peritonei
- MeSH C04.557.470.615 – neoplasms, ductal, lobular, and medullary
- MeSH C04.557.470.615.132 – carcinoma, ductal
- MeSH C04.557.470.615.132.500 – carcinoma, ductal, breast
- MeSH C04.557.470.615.132.750 – carcinoma, pancreatic ductal
- MeSH C04.557.470.615.275 – carcinoma, intraductal, noninfiltrating
- MeSH C04.557.470.615.275.625 – paget's disease, mammary
- MeSH C04.557.470.615.305 – carcinoma, lobular
- MeSH C04.557.470.615.315 – carcinoma, medullary
- MeSH C04.557.470.615.660 – paget's disease, extramammary
- MeSH C04.557.470.615.670 – papilloma, intraductal
- MeSH C04.557.470.625 – neoplasms, fibroepithelial
- MeSH C04.557.470.625.050 – adenofibroma
- MeSH C04.557.470.625.150 – brenner tumor
- MeSH C04.557.470.625.350 – fibroadenoma
- MeSH C04.557.470.660 – neoplasms, mesothelial
- MeSH C04.557.470.660.200 – adenomatoid tumor
- MeSH C04.557.470.660.510 – mesothelioma
- MeSH C04.557.470.660.510.515 – mesothelioma, cystic
- MeSH C04.557.470.670 – neoplasms, neuroepithelial
- MeSH C04.557.470.670.355 – ganglioneuroma
- MeSH C04.557.470.670.380 – glioma
- MeSH C04.557.470.670.380.080 – astrocytoma
- MeSH C04.557.470.670.380.080.335 – glioblastoma
- MeSH C04.557.470.670.380.080.667 – optic nerve glioma
- MeSH C04.557.470.670.380.290 – ependymoma
- MeSH C04.557.470.670.380.290.390 – glioma, subependymal
- MeSH C04.557.470.670.380.350 – ganglioglioma
- MeSH C04.557.470.670.380.400 – gliosarcoma
- MeSH C04.557.470.670.380.515 – medulloblastoma
- MeSH C04.557.470.670.380.590 – oligodendroglioma
- MeSH C04.557.470.670.380.795 – optic nerve glioma
- MeSH C04.557.470.670.580 – neurocytoma
- MeSH C04.557.470.670.590 – neuroectodermal tumors, primitive
- MeSH C04.557.470.670.590.500 – medulloblastoma
- MeSH C04.557.470.670.590.650 – neuroectodermal tumors, primitive, peripheral
- MeSH C04.557.470.670.590.650.550 – neuroblastoma
- MeSH C04.557.470.670.590.650.550.150 – esthesioneuroblastoma, olfactory
- MeSH C04.557.470.670.590.650.550.300 – ganglioneuroblastoma
- MeSH C04.557.470.670.657 – pinealoma
- MeSH C04.557.470.670.725 – retinoblastoma
- MeSH C04.557.470.700 – neoplasms, squamous cell
- MeSH C04.557.470.700.040 – acanthoma
- MeSH C04.557.470.700.360 – carcinoma, papillary
- MeSH C04.557.470.700.400 – carcinoma, squamous cell
- MeSH C04.557.470.700.400.130 – bowen's disease
- MeSH C04.557.470.700.450 – carcinoma, verrucous
- MeSH C04.557.470.700.600 – papilloma
- MeSH C04.557.470.700.600.610 – papilloma, inverted
- MeSH C04.557.580.520 – meningioma
- MeSH C04.557.580.600 – nerve sheath neoplasms
- MeSH C04.557.580.600.290 – neurilemmoma
- MeSH C04.557.580.600.580 – neurofibroma
- MeSH C04.557.580.600.580.585 – neurofibroma, plexiform
- MeSH C04.557.580.600.580.590 – neurofibromatosis
- MeSH C04.557.580.600.580.590.650 – neurofibromatosis 1
- MeSH C04.557.580.600.580.590.655 – neurofibromatosis 2
- MeSH C04.557.580.600.580.795 – neurofibrosarcoma
- MeSH C04.557.580.600.590 – neurofibrosarcoma
- MeSH C04.557.580.600.610 – neuroma
- MeSH C04.557.580.600.610.595 – neurilemmoma
- MeSH C04.557.580.600.610.595.610 – neuroma, acoustic
- MeSH C04.557.580.600.610.595.610.500 – neurofibromatosis 2
- MeSH C04.557.580.600.625 – neurothekeoma
- MeSH C04.557.580.625 – neuroectodermal tumors
- MeSH C04.557.580.625.200 – craniopharyngioma
- MeSH C04.557.580.625.600 – neoplasms, neuroepithelial
- MeSH C04.557.580.625.600.355 – ganglioneuroma
- MeSH C04.557.580.625.600.380 – glioma
- MeSH C04.557.580.625.600.380.080 – astrocytoma
- MeSH C04.557.580.625.600.380.080.335 – glioblastoma
- MeSH C04.557.580.625.600.380.080.667 – optic nerve glioma
- MeSH C04.557.580.625.600.380.290 – ependymoma
- MeSH C04.557.580.625.600.380.290.390 – glioma, subependymal
- MeSH C04.557.580.625.600.380.350 – ganglioglioma
- MeSH C04.557.580.625.600.380.400 – gliosarcoma
- MeSH C04.557.580.625.600.380.515 – medulloblastoma
- MeSH C04.557.580.625.600.380.590 – oligodendroglioma
- MeSH C04.557.580.625.600.380.795 – optic nerve glioma
- MeSH C04.557.580.625.600.580 – neurocytoma
- MeSH C04.557.580.625.600.590 – neuroectodermal tumors, primitive
- MeSH C04.557.580.625.600.590.500 – medulloblastoma
- MeSH C04.557.580.625.600.590.650 – neuroectodermal tumors, primitive, peripheral
- MeSH C04.557.580.625.600.590.650.550 – neuroblastoma
- MeSH C04.557.580.625.600.590.650.550.150 – esthesioneuroblastoma, olfactory
- MeSH C04.557.580.625.600.590.650.550.300 – ganglioneuroblastoma
- MeSH C04.557.580.625.600.657 – pinealoma
- MeSH C04.557.580.625.600.725 – retinoblastoma
- MeSH C04.557.580.625.630 – neuroectodermal tumor, melanotic
- MeSH C04.557.580.625.650 – neuroendocrine tumors
- MeSH C04.557.580.625.650.025 – adenoma, acidophil
- MeSH C04.557.580.625.650.075 – adenoma, basophil
- MeSH C04.557.580.625.650.095 – adenoma, chromophobe
- MeSH C04.557.580.625.650.135 – apudoma
- MeSH C04.557.580.625.650.200 – carcinoid tumor
- MeSH C04.557.580.625.650.200.500 – malignant carcinoid syndrome
- MeSH C04.557.580.625.650.200.500.205 – carcinoid heart disease
- MeSH C04.557.580.625.650.240 – carcinoma, neuroendocrine
- MeSH C04.557.580.625.650.240.315 – carcinoma, medullary
- MeSH C04.557.580.625.650.240.325 – carcinoma, merkel cell
- MeSH C04.557.580.625.650.240.390 – carcinoma, small cell
- MeSH C04.557.580.625.650.510 – melanoma
- MeSH C04.557.580.625.650.510.385 – hutchinson's melanotic freckle
- MeSH C04.557.580.625.650.510.515 – melanoma, amelanotic
- MeSH C04.557.580.625.650.510.525 – melanoma, experimental
- MeSH C04.557.580.625.650.595 – neurilemmoma
- MeSH C04.557.580.625.650.595.610 – neuroma, acoustic
- MeSH C04.557.580.625.650.700 – paraganglioma
- MeSH C04.557.580.625.650.700.705 – paraganglioma, extra-adrenal
- MeSH C04.557.580.625.650.700.705.220 – carotid body tumor
- MeSH C04.557.580.625.650.700.705.340 – glomus jugulare tumor
- MeSH C04.557.580.625.650.700.705.360 – glomus tympanicum tumor
- MeSH C04.557.580.625.650.700.725 – pheochromocytoma
The list continues at List of MeSH codes (C05).
|